Pine Labs logo

Pine Labs

PINELABS NSE

Key Fundamentals

SmallcapFintechFinancial Services
Market Cap
₹18,816 Cr
P/E (TTM)
137.03
EBITDA
₹495 Cr
Return on Equity
1.91%
Debt to Equity
0.07
Book Value
₹51.06
EPS (TTM)
₹1.19
52W High
₹284.00
52W Low
₹134.73

Price-based figures as of 9 Oct 2026, 3:58 pm IST · EPS basis: Consolidated · TTM

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

3
  • Company has reduced debt.
  • Company is almost debt free.
  • Company has delivered good profit growth of 32.3% CAGR over last 5 years

Weaknesses

3
  • Stock is trading at 3.26 times its book value
  • Company has a low return on equity of -2.94% over last 3 years.
  • Company's cost of borrowing seems high

Growth Rate

Revenue Growth
22.35% higher than 3Y
Net Income Growth
-177% lower than 3Y
Cash Flow Change
695% higher than 3Y
EBITDA Margin (Avg.)
49.14% lower than 3Y

AI Analysis — Bull vs Bear

Figures as of 9 Oct 2026
AI opinion · based on fundamentals
Risk high

As of the 2026-10-09 close, Pine Labs Ltd traded at ₹163.07 with a market capitalisation of ₹18,815.96 crore, a trailing P/E of 137.03 on TTM EPS of ₹1.19, and a price-to-book of 3.19. Its balance sheet carries little leverage (debt-to-equity of 0.07), and sales have compounded at 19% over 3 years and 32% over 5 years. Returns are still thin, with ROE at 1.91% and ROCE at 3.62%, and the stock sits about 42.6% below its 52-week high of ₹284.

Bull Case 7
  • The balance sheet is close to debt-free, with debt-to-equity at 0.07. The company has also been reducing debt, which lowers financial risk and leaves room to fund growth.
  • Revenue has compounded at 32% over 5 years and 19% over 3 years, and TTM sales growth is 20%. That shows a steady record of growth in the top line.
  • Profit has grown at a 32% CAGR over 5 years and a 36% CAGR over 3 years. This suggests the business is getting more profitable as it scales.
  • TTM profit growth is 262%. This sharp rise points to operating leverage as the company moves from losses toward steady profits.
  • ROE has improved to 2% in the last year, up from a 3-year average of -3% and a 5-year average of -4%. Returns are now moving in the right direction.
  • At ₹163.07, the stock trades about 42.6% below its 52-week high of ₹284. Part of the earlier valuation premium has already come out of the price.
  • A market capitalisation of ₹18,815.96 crore puts Pine Labs among the larger listed digital payments and merchant-commerce companies in India. That gives it scale as the sector grows.
Bear Case 8
  • A trailing P/E of 137.03 on EPS of just ₹1.19 is an earnings yield of about 0.73%. The valuation depends heavily on profit growth continuing.
  • ROE is only 1.91% and ROCE only 3.62%. Both are well below a typical cost of equity, so the company does not yet earn enough on the capital it uses.
  • ROE averaged -3% over 3 years and -4% over 5 years. The record of positive returns for shareholders is short.
  • A price-to-book of 3.19 combined with an ROE of 1.91% means investors are paying a premium to book value that current returns do not support.
  • The 262% TTM profit growth starts from a very low base. Such a large figure may not hold up as a lasting growth rate.
  • The 52-week range of ₹134.73 to ₹284 means the high was more than double the low, which signals wide price swings. The stock is still about 21% above its 52-week low.
  • Leverage is low (debt-to-equity of 0.07), but the company's borrowing costs look high relative to the debt it carries. That raises its cost of capital.
  • The dividend yield is 0%, so all returns depend on the share price rising.

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

1d ago
Headwinds 4
  • Mastercard fully exits strategic stake Sep 22

    Mastercard Asia/Pacific sold its entire 4.31% stake (4.97 crore shares) for about ₹934 crore at ₹187.75–188 per share. That price was a 7.3% discount to the prior close and about 15% below the ₹221 IPO price. Pine Labs loses a strategic shareholder, and the stock fell more than 3% intraday on Sep 24, its second straight losing session.

  • Persistent share price weakness Sep 29

    The stock fell 2.14% to ₹169.50 on BSE after the Woolworths announcement, down from ₹197.58 on Sep 22. It had already dropped 6% to ₹182.2 on Sep 16 and was down 22.5% year-to-date at that point.

  • Market ignores brokerage upgrades Sep 16

    Pine Labs fell 6% to ₹182.2 on Sep 16 even after brokerages raised targets implying more than 25% upside, while Paytm gained 2.6% the same day. Investors appear to see Pine Labs gaining less from UPI MDR, with Emkay assuming a take rate of only 6bps.

  • UPI competition squeezes merchant economics Sep 23

    Pine Labs competes with Paytm, Razorpay and PhonePe in POS, online payments and affordability products. UPI via QR codes and soundboxes carries low or zero MDR, which weakens the economics of merchant acquiring.

Positives 6
  • UPI MDR triggers target upgrades Sep 16

    NPCI will charge a 0.4% MDR on eligible UPI person-to-merchant payments above ₹2,000 from Oct 15, with acquirers keeping 12bps. Emkay raised its target to ₹230 from ₹190 and Jefferies to ₹235. Jefferies sees ₹1.6 billion of incremental FY28 revenue, about 20% of FY28e EBIT and PAT.

  • Q1 profit up fourfold Sep 23

    Q1 FY27 revenue rose 19.6% YoY to ₹737 crore and PAT rose to ₹19.6 crore from ₹4.8 crore, while expenses grew only 10.6%. DITP revenue grew 15% to ₹499 crore and IAP revenue grew 31%.

  • Institutions absorb Mastercard block Sep 23

    Thirteen institutions bought the stake at ₹187.75, 4.6% above the ₹179.50 floor, led by ICICI Prudential Life (0.80%, ₹174.79 crore), Societe Generale (0.76%) and Citigroup (0.57%). Removing the overhang helped the stock close 2% higher at ₹197.58 on Sep 22.

  • Woolworths partnership extended five years Sep 29

    Subsidiary Qwikcilver renewed its gift card technology partnership with Woolworths Group for another five years, disclosed under SEBI LODR Regulation 30. The renewed deal moves to a modular, API-led architecture for digital and omnichannel stored-value products in Australia and New Zealand.

  • 10 lakh soundbox rollout planned Sep 24

    Pine Labs plans to deploy 10 lakh cloud-first soundboxes across India to take advantage of new UPI monetisation opportunities. UPI processed 22.35 billion transactions worth ₹29.03 lakh crore in April 2026.

  • GHFL adopts card-linked EMI Sep 18

    Garware Hi-Tech Films became the first company in India's auto films and detailing industry to offer card-linked EMI at the point of sale through Pine Labs. It offers 3, 6 and 9-month tenors across 25+ banks and NBFCs on products priced above ₹1.5 lakh.

Neutral 3
  • Google Cloud agentic commerce tie-up Sep 24

    Pine Labs partnered with Google Cloud to build AI-driven agentic commerce for the Indian market. No financial terms or timelines were disclosed.

  • AGM approves director, auditor Sep 16

    Shareholders at the 28th AGM on Sep 16, 2026 approved the re-appointment of Kush Mehra as director and B S R & Co. LLP as statutory auditor.

  • Large-trade signal on NSE Sep 22

    About 11.98 lakh shares worth ₹23.28 crore changed hands at ₹194.33 on NSE. This was a real-time signal, not a confirmed block or bulk deal.

TL;DR: Fundamentals are getting stronger: Q1 FY27 revenue grew about 20%, PAT rose fourfold, and the new UPI MDR from Oct 15 led brokerages to set targets of ₹230–235. Enterprise wins such as the Woolworths renewal and the GHFL EMI deal add to this. The stock is still weak, though: it is down 22.5% YTD, slid from ₹197.58 to ₹169.50 after Mastercard's ₹934 crore exit, and faces UPI pricing pressure from competitors. Fundamentals are improving faster than the price, so the next test is whether UPI MDR revenue after Oct 15 and Q2 results confirm the operating leverage seen in Q1.

Quarterly Results

Particulars Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
552
602
599
616
650
744
701
737
Expenses
519
525
542
571
575
612
594
642
Operating Profit
32
77
57
45
75
132
106
95
OPM %
6%
13%
9%
7%
12%
18%
15%
13%
Other Income
22
-30
12
37
23
23
50
29
Interest
18
22
22
21
21
24
17
13
Depreciation
75
76
69
65
66
68
71
73
PBT
-38
-51
-22
-5
11
63
68
38
Tax %
-16%
11%
30%
-199%
47%
32%
13%
48%
Net Profit
-32
-57
-29
5
6
42
59
20
EPS in Rs
-0.38
-0.67
-0.34
0.11
0.13
0.37
0.52
0.17
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
848
670
932
1,598
1,770
2,274
2,711
2,832
Expenses
760
560
820
1,592
1,794
2,056
2,352
2,423
Operating Profit
87
110
112
5
-25
218
358
409
OPM %
10%
16%
12%
0.3%
-1.4%
10%
13%
14%
Other Income
18
13
25
56
55
16
133
125
Interest
18
22
24
36
64
79
84
76
Depreciation
155
175
189
315
363
292
270
278
PBT
-68
-74
-75
-289
-398
-136
137
180
Tax %
-30%
-25%
-70%
-8%
-14%
7%
18%
—
Net Profit
-47
-56
-23
-265
-342
-145
113
127
EPS in Rs
-3.95
-4.34
-1.67
-18.99
-4.07
-1.73
0.98
1.19
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
12
13
14
0.02
0.1
0.1
115
Reserves
1,035
1,178
1,900
3,664
3,466
3,431
5,781
Borrowings
176
191
236
514
730
1,046
441
Other Liabilities
2,225
3,185
4,111
5,141
5,422
6,222
6,952
Total Liabilities
3,448
4,567
6,260
9,318
9,618
10,698
13,288
Fixed Assets
1,017
980
1,019
2,103
1,920
1,825
1,856
CWIP
52
48
122
269
222
160
148
Investments
40
34
50
18
21
30
28
Other Assets
2,338
3,505
5,070
6,928
7,455
8,683
11,256
Total Assets
3,448
4,567
6,260
9,318
9,618
10,698
13,288
Figures in ₹ Crores

Cash Flow

Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
11
111
-79
-152
-229
50
395
Investing
112
-260
-443
-441
-22
-159
-1,339
Financing
1,431
823
1,644
2
-220
-201
1,972
Net Cash Flow
1,554
674
1,122
-591
-471
-310
1,029
Free Cash Flow
-156
-54
-407
-517
-486
-99
161
CFO/OP
86
114
-25
-1,258
872
5
112
Figures in ₹ Crores

Ratios

Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
92
196
116
135
134
136
140
Inventory Days
5
23
—
134
65
38
32
Days Payable
144
1,345
—
1,233
908
693
382
Cash Conversion Cycle
-47
-1,126
116
-964
-708
-519
-210
Working Capital Days
-722
-1,252
-1,255
-813
-807
-762
-609
ROCE %
—
-4%
-3%
-7%
-8%
0%
4%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Pine Labs insights

58 extracted metrics + investor summaries across FY20–FY27.

Log in — free

Shareholding Pattern

FIIs9.49%Others53.39%Public12.30%DIIs24.82%As ofJun 2026

Documents

Frequently Asked Questions about Pine Labs

What does Pine Labs Ltd do?
Incorporated in 1998, Pine Labs is a leading Indian merchant commerce platform that provides point-of-sale (POS) solutions, payment processing, and merchant financing services.[1]
Where is Pine Labs Ltd (PINELABS) listed?
Pine Labs Ltd trades as PINELABS on the NSE and under code 544606 on the BSE.
Which sector does Pine Labs Ltd belong to?
Pine Labs Ltd is classified under the Financial Services sector, in the Fintech industry.
What is the market capitalisation of Pine Labs Ltd?
Pine Labs Ltd has a market capitalisation of ₹18,816 Cr as of 9 Oct 2026, which places it in the Mid Cap band.
What is the PE ratio of Pine Labs Ltd?
Pine Labs Ltd trades at a PE ratio of 137.03 as of 9 Oct 2026, on earnings per share of ₹1.19, against a book value of ₹51.06 per share.
What is the 52-week high and low of Pine Labs Ltd?
Over the last 52 weeks Pine Labs Ltd has traded between ₹134.73 and ₹284 as of 9 Oct 2026.
What is the Return on Equity (ROE) of Pine Labs Ltd?
Pine Labs Ltd reported a return on equity of 1.91%. Its debt-to-equity ratio is 0.07.

Company Information

Incorporated in 1998, Pine Labs is a leading Indian merchant commerce platform that provides point-of-sale (POS) solutions, payment processing, and merchant financing services.[1]

Website pinelabs.com
Listed 2025-11-14
Face Value ₹ 1
Shares Outstanding 1,15,38,58,090

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/PINELABS.md for Pine Labs Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More